Takayuki Ozawa

Toyonaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Comparison of peripheral neuropathy between Pola-R-CHP and R-CHOP: a retrospective analysis in an ambulatory therapy center

Comparison of peripheral neuropathy between Pola-R-CHP and R-CHOP: a retrospective analysis in an ambulatory therapy center

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Combination therapy with efgartigimod, fostamatinib, eltrombopag and prednisolone for a patient with refractory immune thrombocytopenia

Combination therapy with efgartigimod, fostamatinib, eltrombopag and prednisolone for a patient with refractory immune thrombocytopenia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 05, 2025

Bortezomib Led to Remission of Immune Thrombocytopenic Purpura in a Patient with Smoldering Multiple Myeloma.

Bortezomib Led to Remission of Immune Thrombocytopenic Purpura in a Patient with Smoldering Multiple Myeloma.

Journal: Internal medicine (Tokyo, Japan)

Published: October 20, 2024

Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors.

Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: November 17, 2021

Preparation of monovalent follistatin-like 3-Fc-fusion protein and evaluation of its effects on muscle mass in mice.

Preparation of monovalent follistatin-like 3-Fc-fusion protein and evaluation of its effects on muscle mass in mice.

Journal: STAR protocols

Published: September 29, 2021

Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice.

Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice.

Journal: iScience

Published: November 24, 2020

Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.

Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.

Journal: Stem cells (Dayton, Ohio)

Published: September 30, 2020

A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy.

A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy.

Journal: Annals of hematology

Published: March 10, 2020

The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension.

The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension.

Journal: Science signaling

Published: November 14, 2019

Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis.

Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis.

Journal: Internal medicine (Tokyo, Japan)

Published: September 20, 2019

Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver.

Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver.

Journal: Stem cell reports

Published: February 14, 2019

Palbociclib enhances activin-SMAD-induced cytostasis in estrogen receptor-positive breast cancer.

Palbociclib enhances activin-SMAD-induced cytostasis in estrogen receptor-positive breast cancer.

Journal: Cancer science

Published: August 13, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026